Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance

Heron Therapeutics IncTrade
Roundhill S&P 500 0DTE Covered Call Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $339.46M). The key difference: Roundhill S&P 500 0DTE Covered Call Strategy ETF is far larger — about 4.6× Heron Therapeutics Inc's market cap, and Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.

HRTXXDTE
Market Cap
$74.04M$339.46M
Volume
3,668,095214,614
Sector
HealthIncome / Options Overlay
52-Week High
$1.49$44.76
52-Week Low
$0.27$36.00
Typical Hold Time
35 Days54 Days
Enterprise Value
$180.78M—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.

The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.

Roundhill S&P 500 0DTE Covered Call Strategy ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
XDTE

No sentiment data available yet.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Roundhill S&P 500 0DTE Covered Call Strategy ETF

XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.

Read more on XDTE →